Post-treatment Surveillance in HPV+ Oropharyngeal SCC (NCT04965792)

🧪 Interventions in This Study

• Screening (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Dana Farber Cancer Institute — Boston, Massachusetts

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in HPV

• SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening — Birmingham, Alabama
• Self-sampling for HPV Screening — Sherbrooke, Quebec
• Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening — Austin, Texas
• A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer — Basking Ridge, New Jersey
• Playing Game to Learn About Children's Vaccine Project — Chandler, Arizona

Explore by condition: All HPV clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.